RETREG1 Gene HSAN2B NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Sensory Neuropathy
The RETREG1 Gene HSAN2B NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise identification of mutations associated with Hereditary Sensory and Autonomic Neuropathy Type 2B. This advanced testing methodology utilizes next-generation sequencing technology to provide comprehensive analysis of the RETREG1 gene, enabling accurate diagnosis and personalized management strategies for affected individuals and their families.
What Does This Test Measure?
This specialized genetic test specifically targets the RETREG1 gene, which plays a critical role in maintaining peripheral nerve function. The test detects:
- Pathogenic variants and mutations in the RETREG1 gene
- Single nucleotide polymorphisms associated with HSAN2B
- Insertions, deletions, and copy number variations
- Novel genetic alterations affecting protein function
- Inheritance patterns for family risk assessment
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Progressive sensory loss in extremities
- Autonomic nervous system dysfunction
- Family history of hereditary neuropathy
- Unexplained neurological symptoms beginning in childhood
- Muscle weakness and coordination difficulties
- Temperature regulation abnormalities
- Pain insensitivity leading to injuries
Clinical Benefits of RETREG1 Genetic Testing
Undergoing RETREG1 gene testing provides numerous advantages:
- Definitive Diagnosis: Confirms HSAN2B with 99% accuracy
- Family Planning: Enables informed reproductive decisions
- Early Intervention: Facilitates proactive management strategies
- Personalized Treatment: Guides targeted therapeutic approaches
- Risk Assessment: Identifies at-risk family members
- Research Contribution: Advances understanding of rare neuropathies
Understanding Your Test Results
Our comprehensive genetic counseling services help interpret your results:
- Positive Result: Confirms HSAN2B diagnosis and enables targeted management
- Negative Result: Rules out RETREG1-related neuropathy, suggesting alternative causes
- Variant of Uncertain Significance: Requires additional family studies and monitoring
- Carrier Status: Identifies individuals at risk of passing the condition to offspring
Test Details and Pricing
| Test Parameter | Details |
|---|---|
| Test Name | RETREG1 Gene HSAN2B NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Pre-Test Requirements
Before testing, we recommend:
- Complete clinical history documentation
- Genetic counseling session with our specialists
- Family pedigree chart development
- Discussion of testing implications and expectations
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about hereditary neuropathy conditions affect your quality of life. Our RETREG1 Gene HSAN2B NGS Genetic DNA Test provides the clarity you need for informed healthcare decisions. With our discounted pricing and comprehensive genetic counseling services, accessing advanced neurological genetic testing has never been more accessible.
Call us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are available to answer your questions and guide you through the testing process.
Take the first step toward understanding your genetic health and protecting your family’s neurological future. Contact us now to begin your journey to genetic clarity and personalized healthcare management.
